JP2010533735A5 - - Google Patents

Download PDF

Info

Publication number
JP2010533735A5
JP2010533735A5 JP2010517190A JP2010517190A JP2010533735A5 JP 2010533735 A5 JP2010533735 A5 JP 2010533735A5 JP 2010517190 A JP2010517190 A JP 2010517190A JP 2010517190 A JP2010517190 A JP 2010517190A JP 2010533735 A5 JP2010533735 A5 JP 2010533735A5
Authority
JP
Japan
Prior art keywords
composition
peptide
seq
fragment
sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010517190A
Other languages
English (en)
Japanese (ja)
Other versions
JP5438676B2 (ja
JP2010533735A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2008/070496 external-priority patent/WO2009012460A1/en
Publication of JP2010533735A publication Critical patent/JP2010533735A/ja
Publication of JP2010533735A5 publication Critical patent/JP2010533735A5/ja
Application granted granted Critical
Publication of JP5438676B2 publication Critical patent/JP5438676B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2010517190A 2007-07-19 2008-07-18 癌ワクチンとしてのサバイビンペプチド Active JP5438676B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US96120607P 2007-07-19 2007-07-19
US60/961,206 2007-07-19
PCT/US2008/070496 WO2009012460A1 (en) 2007-07-19 2008-07-18 Survivin peptides as cancer vaccines

Publications (3)

Publication Number Publication Date
JP2010533735A JP2010533735A (ja) 2010-10-28
JP2010533735A5 true JP2010533735A5 (cg-RX-API-DMAC7.html) 2011-07-21
JP5438676B2 JP5438676B2 (ja) 2014-03-12

Family

ID=40260098

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010517190A Active JP5438676B2 (ja) 2007-07-19 2008-07-18 癌ワクチンとしてのサバイビンペプチド

Country Status (8)

Country Link
US (1) US7943138B2 (cg-RX-API-DMAC7.html)
EP (1) EP2178548B1 (cg-RX-API-DMAC7.html)
JP (1) JP5438676B2 (cg-RX-API-DMAC7.html)
KR (1) KR101585042B1 (cg-RX-API-DMAC7.html)
CN (1) CN101754768B (cg-RX-API-DMAC7.html)
CA (1) CA2694011C (cg-RX-API-DMAC7.html)
ES (1) ES2529193T3 (cg-RX-API-DMAC7.html)
WO (1) WO2009012460A1 (cg-RX-API-DMAC7.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006034334A2 (en) * 2004-09-21 2006-03-30 University Of Pittsburgh Of The Commonwealth System Of Higher Education Peptide analogs capable of enhancing stimulation of a glioma-specific ctl response
AU2010275443B2 (en) * 2009-07-24 2016-05-12 Rhode Island Hospital Dendritic cell vaccines for asparaginyl- beta - hydroxylase expressing tumors
CA3066981A1 (en) 2010-08-24 2012-03-01 University Of Pittsburgh - Of The Commonwealth System Of Higher Educatn Interleukin-13 receptor alpha 2 peptide-based brain cancer vaccines
US10485858B2 (en) 2012-05-16 2019-11-26 Stemline Therapeutics, Inc. Cancer stem cell targeted cancer vaccines
CN120514834A (zh) 2014-03-28 2025-08-22 华盛顿大学商业中心 乳腺癌和卵巢癌疫苗
PL3335725T3 (pl) 2015-08-10 2024-07-22 Toray Industries, Inc. Epitopy PDS5A jako induktory odporności
CN108883163B (zh) * 2015-09-04 2022-04-15 健康研究公司 用于癌症治疗的抗存活蛋白抗体
GB201604755D0 (en) * 2016-03-21 2016-05-04 Vaxeal Res Sas Immunogenic compositions
WO2025159614A1 (ko) * 2024-01-23 2025-07-31 한양대학교 산학협력단 데옥시콜산과 연결된 암항원 펩타이드를 포함하는 나노구조체 및 이의 용도

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040142325A1 (en) * 2001-09-14 2004-07-22 Liat Mintz Methods and systems for annotating biomolecular sequences
US7892559B2 (en) * 2002-01-30 2011-02-22 Survac Aps Survivin-derived peptides and use thereof
US20060073159A1 (en) * 2004-05-25 2006-04-06 The Trustees Of The University Of Pennsylvania Human anti-cancer immunotherapy
US20070104689A1 (en) * 2005-09-27 2007-05-10 Merck Patent Gmbh Compositions and methods for treating tumors presenting survivin antigens

Similar Documents

Publication Publication Date Title
JP2010533735A5 (cg-RX-API-DMAC7.html)
NZ710626A (en) Pcsk9 vaccine
EP2583976A3 (en) Peptide vaccines with SEQ ID NO: 210, 196, 202, 213, 214, 214 or 223 for cancers expressing tumor-associated antigens
RU2020113032A (ru) Новые пептиды и комбинации пептидов для применения в иммунотерапии рака легких, в том числе немелкоклеточного рака легких (нмрл) и других видов рака
HRP20150873T1 (hr) Pripravci i postupci za lijeäśenje celijakije
ME02692B (me) NOVA IMUNOTERAPIJA PROTIV NEKOLIKO TUMORA UKLJUČUJUĆI GASTROINTESTINALNI KARCINOM l KARCINOM ŽELUCA
JP2010166921A5 (cg-RX-API-DMAC7.html)
WO2008140621A3 (en) Transgenic oncolytic viruses and uses thereof
NZ608972A (en) Engineered nucleic acids and methods of use thereof
UA110599C2 (uk) Пептид для імунотерапії пухлин, включаючи нейрональні пухлини та пухлини мозку
JP2010540453A5 (cg-RX-API-DMAC7.html)
NZ601818A (en) Composition of tumor-associated peptides and related anti-cancer vaccine for the treatment of gastric cancer and other cancers
UA110806C2 (uk) Мікобактеріальна антигенна композиція
RU2010125605A (ru) Антитело против глипикана-3 с улучшенными кинетическими показателями в плазме
AR049177A1 (es) Polipeptidos y conjugados de interferon-alfa
JP2017523985A5 (cg-RX-API-DMAC7.html)
EP3676380B1 (en) Rna nanostructures and methods of making and using rna nanostructures
CN103804482B (zh) 一种抗菌肽及其应用
RU2017126566A (ru) ВСТРЕЧАЮЩИЕСЯ В ПРИРОДЕ миРНК ДЛЯ КОНТРОЛИРОВАНИЯ ЭКСПРЕССИИ ГЕНОВ И ИХ ПРИМЕНЕНИЕ
JP2014527801A5 (cg-RX-API-DMAC7.html)
JP2015524788A5 (cg-RX-API-DMAC7.html)
MX2007008980A (es) Acidos nucleicos para apoptosis de celulas cancerigenas.
RU2013111675A (ru) Рекомбинантный fc-гибридный белок пятого домена фибронектина типа iii dcc
JP2015529629A5 (cg-RX-API-DMAC7.html)
CN103589693A (zh) 一种表达ibdv vp2和法氏囊素三肽嵌合蛋白重组火鸡疱疹病毒